Skip to main content
Top
Published in: Arthritis Research & Therapy 6/2012

01-12-2012 | Review

An update on the hyper-IgE syndromes

Authors: Patrick FK Yong, Alexandra F Freeman, Karin R Engelhardt, Steven Holland, Jennifer M Puck, Bodo Grimbacher

Published in: Arthritis Research & Therapy | Issue 6/2012

Login to get access

Abstract

The hyper-IgE syndromes (HIES; originally named Job's syndrome) are a collection of primary immunodeficiency syndromes resulting in elevated serum IgE levels and typified by recurrent staphylococcal skin abscesses, eczema and pulmonary infections. The disorder has autosomal dominant and recessive forms. Autosomal dominant HIES has been shown to be mainly due to STAT3 mutations and additionally results in connective tissue, skeletal, vascular and dental abnormalities. Autosomal recessive HIES has been shown to be mainly due to mutations in DOCK8; these patients are more prone to viral skin infections instead. This review article discusses the common clinical features of the syndrome, the genetic mutations responsible and the pathogenesis of the disease, as well as treatments currently used.
Appendix
Available only for authorised users
Literature
1.
go back to reference Davis SD, Schaller J, Wedgwood RJ: Job's Syndrome. Recurrent, "cold", staphylococcal abscesses. Lancet. 1966, 1: 1013-1015.CrossRefPubMed Davis SD, Schaller J, Wedgwood RJ: Job's Syndrome. Recurrent, "cold", staphylococcal abscesses. Lancet. 1966, 1: 1013-1015.CrossRefPubMed
2.
go back to reference Buckley RH, Wray BB, Belmaker EZ: Extreme hyperimmunoglobulinemia E and undue susceptibility to infection. Pediatrics. 1972, 49: 59-70.PubMed Buckley RH, Wray BB, Belmaker EZ: Extreme hyperimmunoglobulinemia E and undue susceptibility to infection. Pediatrics. 1972, 49: 59-70.PubMed
3.
go back to reference Hill HR, Ochs HD, Quie PG, Clark RA, Pabst HF, Klebanoff SJ, Wedgwood RJ: Defect in neutrophil granulocyte chemotaxis in Job's syndrome of recurrent "cold" staphylococcal abscesses. Lancet. 1974, 2: 617-619.CrossRefPubMed Hill HR, Ochs HD, Quie PG, Clark RA, Pabst HF, Klebanoff SJ, Wedgwood RJ: Defect in neutrophil granulocyte chemotaxis in Job's syndrome of recurrent "cold" staphylococcal abscesses. Lancet. 1974, 2: 617-619.CrossRefPubMed
4.
go back to reference Grimbacher B, Holland SM, Gallin JI, Greenberg F, Hill SC, Malech HL, Miller JA, O'Connell AC, Puck JM: Hyper-IgE syndrome with recurrent infections--an autosomal dominant multisystem disorder. N Engl J Med. 1999, 340: 692-702. 10.1056/NEJM199903043400904.CrossRefPubMed Grimbacher B, Holland SM, Gallin JI, Greenberg F, Hill SC, Malech HL, Miller JA, O'Connell AC, Puck JM: Hyper-IgE syndrome with recurrent infections--an autosomal dominant multisystem disorder. N Engl J Med. 1999, 340: 692-702. 10.1056/NEJM199903043400904.CrossRefPubMed
5.
go back to reference Holland SM, DeLeo FR, Elloumi HZ, Hsu AP, Uzel G, Brodsky N, Freeman AF, Demidowich A, Davis J, Turner ML, Anderson VL, Darnell DN, Welch PA, Kuhns DB, Frucht DM, Malech HL, Gallin JI, Kobayashi SD, Whitney AR, Voyich JM, Musser JM, Woellner C, Schäffer AA, Puck JM, Grimbacher B: STAT3 mutations in the hyper-IgE syndrome. N Engl J Med. 2007, 357: 1608-1619. 10.1056/NEJMoa073687.CrossRefPubMed Holland SM, DeLeo FR, Elloumi HZ, Hsu AP, Uzel G, Brodsky N, Freeman AF, Demidowich A, Davis J, Turner ML, Anderson VL, Darnell DN, Welch PA, Kuhns DB, Frucht DM, Malech HL, Gallin JI, Kobayashi SD, Whitney AR, Voyich JM, Musser JM, Woellner C, Schäffer AA, Puck JM, Grimbacher B: STAT3 mutations in the hyper-IgE syndrome. N Engl J Med. 2007, 357: 1608-1619. 10.1056/NEJMoa073687.CrossRefPubMed
6.
go back to reference Minegishi Y, Saito M, Tsuchiya S, Tsuge I, Takada H, Hara T, Kawamura N, Ariga T, Pasic S, Stojkovic O, Metin A, Karasuyama H: Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature. 2007, 448: 1058-1062. 10.1038/nature06096.CrossRefPubMed Minegishi Y, Saito M, Tsuchiya S, Tsuge I, Takada H, Hara T, Kawamura N, Ariga T, Pasic S, Stojkovic O, Metin A, Karasuyama H: Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature. 2007, 448: 1058-1062. 10.1038/nature06096.CrossRefPubMed
8.
go back to reference Chamlin SL, McCalmont TH, Cunningham BB, Esterly NB, Lai CH, Mallory SB, Mancini AJ, Tamburro J, Frieden IJ: Cutaneous manifestations of hyper-IgE syndrome in infants and children. J Pediatr. 2002, 141: 572-575. 10.1067/mpd.2002.127503.CrossRefPubMed Chamlin SL, McCalmont TH, Cunningham BB, Esterly NB, Lai CH, Mallory SB, Mancini AJ, Tamburro J, Frieden IJ: Cutaneous manifestations of hyper-IgE syndrome in infants and children. J Pediatr. 2002, 141: 572-575. 10.1067/mpd.2002.127503.CrossRefPubMed
9.
go back to reference Eberting CL, Davis J, Puck JM, Holland SM, Turner ML: Dermatitis and the newborn rash of hyper-IgE syndrome. Arch Dermatol. 2004, 140: 1119-1125. 10.1001/archderm.140.9.1119.CrossRefPubMed Eberting CL, Davis J, Puck JM, Holland SM, Turner ML: Dermatitis and the newborn rash of hyper-IgE syndrome. Arch Dermatol. 2004, 140: 1119-1125. 10.1001/archderm.140.9.1119.CrossRefPubMed
10.
go back to reference Erlewyn-Lajeunesse MD: Hyperimmunoglobulin-E syndrome with recurrent infection: a review of current opinion and treatment. Pediatr Allergy Immunol. 2000, 11: 133-141. 10.1034/j.1399-3038.2000.00091.x.CrossRefPubMed Erlewyn-Lajeunesse MD: Hyperimmunoglobulin-E syndrome with recurrent infection: a review of current opinion and treatment. Pediatr Allergy Immunol. 2000, 11: 133-141. 10.1034/j.1399-3038.2000.00091.x.CrossRefPubMed
11.
go back to reference Melia E, Freeman AF, Shea YR, Hsu AP, Holland SM, Olivier KN: Pulmonary nontuberculous mycobacterial infections in hyper-IgE syndrome. J Allergy Clin Immunol. 2009, 124: 617-618. 10.1016/j.jaci.2009.07.007.PubMedCentralCrossRefPubMed Melia E, Freeman AF, Shea YR, Hsu AP, Holland SM, Olivier KN: Pulmonary nontuberculous mycobacterial infections in hyper-IgE syndrome. J Allergy Clin Immunol. 2009, 124: 617-618. 10.1016/j.jaci.2009.07.007.PubMedCentralCrossRefPubMed
12.
go back to reference Vinh DC, Sugui JA, Hsu AP, Freeman AF, Holland SM: Invasive fungal disease in autosomal-dominant hyper-IgE syndrome. J Allergy Clin Immunol. 2010, 125: 1389-1390. 10.1016/j.jaci.2010.01.047.PubMedCentralCrossRefPubMed Vinh DC, Sugui JA, Hsu AP, Freeman AF, Holland SM: Invasive fungal disease in autosomal-dominant hyper-IgE syndrome. J Allergy Clin Immunol. 2010, 125: 1389-1390. 10.1016/j.jaci.2010.01.047.PubMedCentralCrossRefPubMed
13.
go back to reference Freeman AF, Kleiner DE, Nadiminti H, Davis J, Quezado M, Anderson V, Puck JM, Holland SM: Causes of death in hyper-IgE syndrome. J Allergy Clin Immunol. 2007, 119: 1234-1240. 10.1016/j.jaci.2006.12.666.CrossRefPubMed Freeman AF, Kleiner DE, Nadiminti H, Davis J, Quezado M, Anderson V, Puck JM, Holland SM: Causes of death in hyper-IgE syndrome. J Allergy Clin Immunol. 2007, 119: 1234-1240. 10.1016/j.jaci.2006.12.666.CrossRefPubMed
14.
go back to reference Freeman AF, Davis J, Anderson VL, Barson W, Darnell DN, Puck JM, Holland SM: Pneumocystis jiroveci infection in patients with hyper-immunoglobulin E syndrome. Pediatrics. 2006, 118: e1271-e1275. 10.1542/peds.2006-0311.CrossRefPubMed Freeman AF, Davis J, Anderson VL, Barson W, Darnell DN, Puck JM, Holland SM: Pneumocystis jiroveci infection in patients with hyper-immunoglobulin E syndrome. Pediatrics. 2006, 118: e1271-e1275. 10.1542/peds.2006-0311.CrossRefPubMed
15.
go back to reference Garty BZ, Ben-Baruch A, Rolinsky A, Woellner C, Grimbacher B, Marcus N: Pneumocystis jirovecii pneumonia in a baby with hyper-IgE syndrome. Eur J Pediatr. 2010, 169: 35-37. 10.1007/s00431-009-0973-5.CrossRefPubMed Garty BZ, Ben-Baruch A, Rolinsky A, Woellner C, Grimbacher B, Marcus N: Pneumocystis jirovecii pneumonia in a baby with hyper-IgE syndrome. Eur J Pediatr. 2010, 169: 35-37. 10.1007/s00431-009-0973-5.CrossRefPubMed
16.
go back to reference Jacobs DH, Macher AM, Handler R, Bennett JE, Collen MJ, Gallin JI: Esophageal cryptococcosis in a patient with the hyperimmunoglobulin E-recurrent infection (Job's) syndrome. Gastroenterology. 1984, 87: 201-203.PubMed Jacobs DH, Macher AM, Handler R, Bennett JE, Collen MJ, Gallin JI: Esophageal cryptococcosis in a patient with the hyperimmunoglobulin E-recurrent infection (Job's) syndrome. Gastroenterology. 1984, 87: 201-203.PubMed
17.
go back to reference Hutto JO, Bryan CS, Greene FL, White CJ, Gallin JI: Cryptococcosis of the colon resembling Crohn's disease in a patient with the hyperimmunoglobulinemia E-recurrent infection (Job's) syndrome. Gastroenterology. 1988, 94: 808-812.PubMed Hutto JO, Bryan CS, Greene FL, White CJ, Gallin JI: Cryptococcosis of the colon resembling Crohn's disease in a patient with the hyperimmunoglobulinemia E-recurrent infection (Job's) syndrome. Gastroenterology. 1988, 94: 808-812.PubMed
18.
go back to reference Borges WG, Hensley T, Carey JC, Petrak BA, Hill HR: The face of Job. J Pediatr. 1998, 133: 303-305. 10.1016/S0022-3476(98)70243-4.CrossRefPubMed Borges WG, Hensley T, Carey JC, Petrak BA, Hill HR: The face of Job. J Pediatr. 1998, 133: 303-305. 10.1016/S0022-3476(98)70243-4.CrossRefPubMed
19.
go back to reference Freeman AF, Collura-Burke CJ, Patronas NJ, Ilcus LS, Darnell D, Davis J, Puck JM, Holland SM: Brain abnormalities in patients with hyperimmunoglobulin E syndrome. Pediatrics. 2007, 119: e1121-e1125. 10.1542/peds.2006-2649.CrossRefPubMed Freeman AF, Collura-Burke CJ, Patronas NJ, Ilcus LS, Darnell D, Davis J, Puck JM, Holland SM: Brain abnormalities in patients with hyperimmunoglobulin E syndrome. Pediatrics. 2007, 119: e1121-e1125. 10.1542/peds.2006-2649.CrossRefPubMed
20.
go back to reference Hoger PH, Boltshauser E, Hitzig WH: Craniosynostosis in hyper-IgEsyndrome. Eur J Pediatr. 1985, 144: 414-417. 10.1007/BF00441793.CrossRefPubMed Hoger PH, Boltshauser E, Hitzig WH: Craniosynostosis in hyper-IgEsyndrome. Eur J Pediatr. 1985, 144: 414-417. 10.1007/BF00441793.CrossRefPubMed
21.
go back to reference Smithwick EM, Finelt M, Pahwa S, Good RA, Naspitz CK, Mendes NF, Kopersztyk S, Spira TJ, Nahmias AJ: Cranial synostosis in Job's syndrome. Lancet. 1978, 1: 826-CrossRefPubMed Smithwick EM, Finelt M, Pahwa S, Good RA, Naspitz CK, Mendes NF, Kopersztyk S, Spira TJ, Nahmias AJ: Cranial synostosis in Job's syndrome. Lancet. 1978, 1: 826-CrossRefPubMed
22.
go back to reference O'Connell AC, Puck JM, Grimbacher B, Facchetti F, Majorana A, Gallin JI, Malech HL, Holland SM: Delayed eruption of permanent teeth in hyperimmunoglobulinemia E recurrent infection syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000, 89: 177-185. 10.1067/moe.2000.103129.CrossRefPubMed O'Connell AC, Puck JM, Grimbacher B, Facchetti F, Majorana A, Gallin JI, Malech HL, Holland SM: Delayed eruption of permanent teeth in hyperimmunoglobulinemia E recurrent infection syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000, 89: 177-185. 10.1067/moe.2000.103129.CrossRefPubMed
23.
go back to reference Domingo DL, Freeman AF, Davis J, Puck JM, Tianxia W, Holland SM, Hart TC: Novel intraoral phenotypes in hyperimmunoglobulin-E syndrome. Oral Dis. 2008, 14: 73-81.PubMed Domingo DL, Freeman AF, Davis J, Puck JM, Tianxia W, Holland SM, Hart TC: Novel intraoral phenotypes in hyperimmunoglobulin-E syndrome. Oral Dis. 2008, 14: 73-81.PubMed
24.
go back to reference Ling JC, Freeman AF, Gharib AM, Arai AE, Lederman RJ, Rosing DR, Holland SM: Coronary artery aneurysms in patients with hyper IgE recurrent infection syndrome. Clin Immunol. 2007, 122: 255-258. 10.1016/j.clim.2006.10.005.CrossRefPubMed Ling JC, Freeman AF, Gharib AM, Arai AE, Lederman RJ, Rosing DR, Holland SM: Coronary artery aneurysms in patients with hyper IgE recurrent infection syndrome. Clin Immunol. 2007, 122: 255-258. 10.1016/j.clim.2006.10.005.CrossRefPubMed
25.
go back to reference Young TY, Jerome D, Gupta S: Hyperimmunoglobulinemia E syndrome associated with coronary artery aneurysms: deficiency of central memory CD4+ T cells and expansion of effector memory CD4+ T cells. Ann Allergy Asthma Immunol. 2007, 98: 389-392. 10.1016/S1081-1206(10)60887-3.CrossRefPubMed Young TY, Jerome D, Gupta S: Hyperimmunoglobulinemia E syndrome associated with coronary artery aneurysms: deficiency of central memory CD4+ T cells and expansion of effector memory CD4+ T cells. Ann Allergy Asthma Immunol. 2007, 98: 389-392. 10.1016/S1081-1206(10)60887-3.CrossRefPubMed
26.
go back to reference Chandesris MO, Azarine A, Ong KT, Taleb S, Boutouyrie P, Mousseaux E, Romain M, Bozec E, Laurent S, Boddaert N, Thumerelle C, Tillie-Leblond I, Hoarau C, Lebranchu Y, Aladjidi N, Tron F, Barlogis V, Body G, Munzer M, Jaussaud R, Suarez F, Clément O, Hermine O, Tedgui A, Lortholary O, Picard C, Mallat Z, Fischer A: Frequent and widespread vascular abnormalities in human signal transducer and activator of transcription 3 deficiency. Circ Cardiovasc Genet. 2012, 5: 25-34. 10.1161/CIRCGENETICS.111.961235.CrossRefPubMed Chandesris MO, Azarine A, Ong KT, Taleb S, Boutouyrie P, Mousseaux E, Romain M, Bozec E, Laurent S, Boddaert N, Thumerelle C, Tillie-Leblond I, Hoarau C, Lebranchu Y, Aladjidi N, Tron F, Barlogis V, Body G, Munzer M, Jaussaud R, Suarez F, Clément O, Hermine O, Tedgui A, Lortholary O, Picard C, Mallat Z, Fischer A: Frequent and widespread vascular abnormalities in human signal transducer and activator of transcription 3 deficiency. Circ Cardiovasc Genet. 2012, 5: 25-34. 10.1161/CIRCGENETICS.111.961235.CrossRefPubMed
27.
go back to reference Alomar-Melero E, Martin TD, Janelle GM, Peng YG: An unusual giant right coronary artery aneurysm resembles an intracardiac mass. Anesth Analg. 2008, 107: 1161-1162. 10.1213/ane.0b013e318181f74f.CrossRefPubMed Alomar-Melero E, Martin TD, Janelle GM, Peng YG: An unusual giant right coronary artery aneurysm resembles an intracardiac mass. Anesth Analg. 2008, 107: 1161-1162. 10.1213/ane.0b013e318181f74f.CrossRefPubMed
28.
go back to reference Freeman AF, Avila EM, Shaw PA, Davis J, Hsu AP, Welch P, Matta JR, Hadigan C, Pettigrew RI, Holland SM, Gharib AM: Coronary artery abnormalities in Hyper-IgE syndrome. J Clin Immunol. 2011, 31: 338-345. 10.1007/s10875-011-9515-9.PubMedCentralCrossRefPubMed Freeman AF, Avila EM, Shaw PA, Davis J, Hsu AP, Welch P, Matta JR, Hadigan C, Pettigrew RI, Holland SM, Gharib AM: Coronary artery abnormalities in Hyper-IgE syndrome. J Clin Immunol. 2011, 31: 338-345. 10.1007/s10875-011-9515-9.PubMedCentralCrossRefPubMed
29.
go back to reference Gorin LJ, Jeha SC, Sullivan MP, Rosenblatt HM, Shearer WT: Burkitt's lymphoma developing in a 7-year-old boy with hyper-IgE syndrome. J Allergy Clin Immunol. 1989, 83: 5-10. 10.1016/0091-6749(89)90471-5.CrossRefPubMed Gorin LJ, Jeha SC, Sullivan MP, Rosenblatt HM, Shearer WT: Burkitt's lymphoma developing in a 7-year-old boy with hyper-IgE syndrome. J Allergy Clin Immunol. 1989, 83: 5-10. 10.1016/0091-6749(89)90471-5.CrossRefPubMed
30.
go back to reference Leonard GD, Posadas E, Herrmann PC, Anderson VL, Jaffe ES, Holland SM, Wilson WH: Non-Hodgkin's lymphoma in Job's syndrome: a case report and literature review. Leuk Lymphoma. 2004, 45: 2521-2525. 10.1080/10428190400004463.CrossRefPubMed Leonard GD, Posadas E, Herrmann PC, Anderson VL, Jaffe ES, Holland SM, Wilson WH: Non-Hodgkin's lymphoma in Job's syndrome: a case report and literature review. Leuk Lymphoma. 2004, 45: 2521-2525. 10.1080/10428190400004463.CrossRefPubMed
31.
go back to reference Kumanovics A, Perkins SL, Gilbert H, Cessna MH, Augustine NH, Hill HR: Diffuse large B cell lymphoma in hyper-IgE syndrome due to STAT3 mutation. J Clin Immunol. 2010, 30: 886-893. 10.1007/s10875-010-9452-z.CrossRefPubMed Kumanovics A, Perkins SL, Gilbert H, Cessna MH, Augustine NH, Hill HR: Diffuse large B cell lymphoma in hyper-IgE syndrome due to STAT3 mutation. J Clin Immunol. 2010, 30: 886-893. 10.1007/s10875-010-9452-z.CrossRefPubMed
32.
go back to reference Clark TJ, Herod JJ, Kehoe S, Luesley DM: The development of invasive vulvar cancer in a patient with Job's syndrome, a rare immunodeficient condition. Br J Obstet Gynaecol. 1998, 105: 468-470. 10.1111/j.1471-0528.1998.tb10137.x.CrossRefPubMed Clark TJ, Herod JJ, Kehoe S, Luesley DM: The development of invasive vulvar cancer in a patient with Job's syndrome, a rare immunodeficient condition. Br J Obstet Gynaecol. 1998, 105: 468-470. 10.1111/j.1471-0528.1998.tb10137.x.CrossRefPubMed
33.
go back to reference Oztop I, Demirkan B, Tarhan O, Kayahan H, Yilmaz U, Kargi A, Alakavuklar M: The development of pulmonary adenocarcinoma in a patient with Job's syndrome, a rare immunodeficiency condition. Tumori. 2004, 90: 132-135.PubMed Oztop I, Demirkan B, Tarhan O, Kayahan H, Yilmaz U, Kargi A, Alakavuklar M: The development of pulmonary adenocarcinoma in a patient with Job's syndrome, a rare immunodeficiency condition. Tumori. 2004, 90: 132-135.PubMed
34.
go back to reference Min JK, Cho ML, Kim SC, Lee YS, Lee SH, Park SH, Hong YS, Cho CS, Kim HY: Hyperimmunoglobulin E-recurrent infection syndrome in a patient with juvenile dermatomyositis. Korean J Intern Med. 1999, 14: 95-98.PubMedCentralCrossRefPubMed Min JK, Cho ML, Kim SC, Lee YS, Lee SH, Park SH, Hong YS, Cho CS, Kim HY: Hyperimmunoglobulin E-recurrent infection syndrome in a patient with juvenile dermatomyositis. Korean J Intern Med. 1999, 14: 95-98.PubMedCentralCrossRefPubMed
35.
go back to reference Kimata H: High-dose intravenous gamma-globulin treatment for hyperimmunoglobulinemia E syndrome. J Allergy Clin Immunol. 1995, 95: 771-774. 10.1016/S0091-6749(95)70185-0.CrossRefPubMed Kimata H: High-dose intravenous gamma-globulin treatment for hyperimmunoglobulinemia E syndrome. J Allergy Clin Immunol. 1995, 95: 771-774. 10.1016/S0091-6749(95)70185-0.CrossRefPubMed
36.
go back to reference Tanji C, Yorioka N, Kanahara K, Naito T, Oda H, Ishikawa K, Taguchi T: Hyperimmunoglobulin E syndrome associated with nephrotic syndrome. Intern Med. 1999, 38: 491-494. 10.2169/internalmedicine.38.491.CrossRefPubMed Tanji C, Yorioka N, Kanahara K, Naito T, Oda H, Ishikawa K, Taguchi T: Hyperimmunoglobulin E syndrome associated with nephrotic syndrome. Intern Med. 1999, 38: 491-494. 10.2169/internalmedicine.38.491.CrossRefPubMed
37.
go back to reference Brugnoni D, Franceschini F, Airo P, Cattaneo R: Discordance for systemic lupus erythematosus and hyper IgE syndrome in a pair of monozygotic twins. Br J Rheumatol. 1998, 37: 807-808.CrossRefPubMed Brugnoni D, Franceschini F, Airo P, Cattaneo R: Discordance for systemic lupus erythematosus and hyper IgE syndrome in a pair of monozygotic twins. Br J Rheumatol. 1998, 37: 807-808.CrossRefPubMed
38.
go back to reference North J, Kotecha S, Houtman P, Whaley K: Systemic lupus erythematosus complicating hyper IgE syndrome. Br J Rheumatol. 1997, 36: 297-298. 10.1093/rheumatology/36.2.297.CrossRefPubMed North J, Kotecha S, Houtman P, Whaley K: Systemic lupus erythematosus complicating hyper IgE syndrome. Br J Rheumatol. 1997, 36: 297-298. 10.1093/rheumatology/36.2.297.CrossRefPubMed
39.
go back to reference Berger M, Kirkpatrick CH, Goldsmith PK, Gallin JI: IgE antibodies to Staphylococcus aureus and Candida albicans in patients with the syndrome of hyperimmunoglobulin E and recurrent infections. J Immunol. 1980, 125: 2437-2443.PubMed Berger M, Kirkpatrick CH, Goldsmith PK, Gallin JI: IgE antibodies to Staphylococcus aureus and Candida albicans in patients with the syndrome of hyperimmunoglobulin E and recurrent infections. J Immunol. 1980, 125: 2437-2443.PubMed
40.
go back to reference Donabedian H, Gallin JI: The hyperimmunoglobulin E recurrent-infection (Job's) syndrome. A review of the NIH experience and the literature. Medicine (Baltimore). 1983, 62: 195-208.CrossRef Donabedian H, Gallin JI: The hyperimmunoglobulin E recurrent-infection (Job's) syndrome. A review of the NIH experience and the literature. Medicine (Baltimore). 1983, 62: 195-208.CrossRef
41.
go back to reference Buckley RH: The hyper-IgE syndrome. Clin Rev Allergy Immunol. 2001, 20: 139-154. 10.1385/CRIAI:20:1:139.CrossRefPubMed Buckley RH: The hyper-IgE syndrome. Clin Rev Allergy Immunol. 2001, 20: 139-154. 10.1385/CRIAI:20:1:139.CrossRefPubMed
42.
go back to reference Speckmann C, Enders A, Woellner C, Thiel D, Rensing-Ehl A, Schlesier M, Rohr J, Jakob T, Oswald E, Kopp MV, Sanal O, Litzman J, Plebani A, Pietrogrande MC, Franco JL, Espanol T, Grimbacher B, Ehl S: Reduced memory B cells in patients with hyper IgE syndrome. Clin Immunol. 2008, 129: 448-454. 10.1016/j.clim.2008.08.002.CrossRefPubMed Speckmann C, Enders A, Woellner C, Thiel D, Rensing-Ehl A, Schlesier M, Rohr J, Jakob T, Oswald E, Kopp MV, Sanal O, Litzman J, Plebani A, Pietrogrande MC, Franco JL, Espanol T, Grimbacher B, Ehl S: Reduced memory B cells in patients with hyper IgE syndrome. Clin Immunol. 2008, 129: 448-454. 10.1016/j.clim.2008.08.002.CrossRefPubMed
43.
go back to reference Siegel AM, Heimall J, Freeman AF, Hsu AP, Brittain E, Brenchley JM, Douek DC, Fahle GH, Cohen JI, Holland SM, Milner JD: A critical role for STAT3 transcription factor signaling in the development and maintenance of human T cell memory. Immunity. 2011, 35: 806-818. 10.1016/j.immuni.2011.09.016.PubMedCentralCrossRefPubMed Siegel AM, Heimall J, Freeman AF, Hsu AP, Brittain E, Brenchley JM, Douek DC, Fahle GH, Cohen JI, Holland SM, Milner JD: A critical role for STAT3 transcription factor signaling in the development and maintenance of human T cell memory. Immunity. 2011, 35: 806-818. 10.1016/j.immuni.2011.09.016.PubMedCentralCrossRefPubMed
44.
go back to reference Renner ED, Rylaarsdam S, Anover-Sombke S, Rack AL, Reichenbach J, Carey JC, Zhu Q, Jansson AF, Barboza J, Schimke LF, Leppert MF, Getz MM, Seger RA, Hill HR, Belohradsky BH, Torgerson TR, Ochs HD: Novel signal transducer and activator of transcription 3 (STAT3) mutations, reduced T(H)17 cell numbers, and variably defective STAT3 phosphorylation in hyper-IgE syndrome. J Allergy Clin Immunol. 2008, 122: 181-187. 10.1016/j.jaci.2008.04.037.PubMedCentralCrossRefPubMed Renner ED, Rylaarsdam S, Anover-Sombke S, Rack AL, Reichenbach J, Carey JC, Zhu Q, Jansson AF, Barboza J, Schimke LF, Leppert MF, Getz MM, Seger RA, Hill HR, Belohradsky BH, Torgerson TR, Ochs HD: Novel signal transducer and activator of transcription 3 (STAT3) mutations, reduced T(H)17 cell numbers, and variably defective STAT3 phosphorylation in hyper-IgE syndrome. J Allergy Clin Immunol. 2008, 122: 181-187. 10.1016/j.jaci.2008.04.037.PubMedCentralCrossRefPubMed
45.
go back to reference Ma CS, Chew GY, Simpson N, Priyadarshi A, Wong M, Grimbacher B, Fulcher DA, Tangye SG, Cook MC: Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3. J Exp Med. 2008, 205: 1551-1557. 10.1084/jem.20080218.PubMedCentralCrossRefPubMed Ma CS, Chew GY, Simpson N, Priyadarshi A, Wong M, Grimbacher B, Fulcher DA, Tangye SG, Cook MC: Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3. J Exp Med. 2008, 205: 1551-1557. 10.1084/jem.20080218.PubMedCentralCrossRefPubMed
46.
go back to reference Jiao H, Tóth B, Erdos M, Fransson I, Rákóczi E, Balogh I, Magyarics Z, Dérfalvi B, Csorba G, Szaflarska A, Megarbane A, Akatcherian C, Dbaibo G, Rajnavölgyi E, Hammarstróm L, Kere J, Lefranc G, Marodi L: Novel and recurrent STAT3 mutations in hyper-IgE syndrome patients from different ethnic groups. Mol Immunol. 2008, 46: 202-206. 10.1016/j.molimm.2008.07.001.CrossRefPubMed Jiao H, Tóth B, Erdos M, Fransson I, Rákóczi E, Balogh I, Magyarics Z, Dérfalvi B, Csorba G, Szaflarska A, Megarbane A, Akatcherian C, Dbaibo G, Rajnavölgyi E, Hammarstróm L, Kere J, Lefranc G, Marodi L: Novel and recurrent STAT3 mutations in hyper-IgE syndrome patients from different ethnic groups. Mol Immunol. 2008, 46: 202-206. 10.1016/j.molimm.2008.07.001.CrossRefPubMed
47.
go back to reference de Beaucoudrey L, Puel A, Filipe-Santos O, Cobat A, Ghandil P, Chrabieh M, Feinberg J, von Bernuth H, Samarina A, Jannière L, Fieschi C, Stéphan JL, Boileau C, Lyonnet S, Jondeau G, Cormier-Daire V, Le Merrer M, Hoarau C, Lebranchu Y, Lortholary O, Chandesris MO, Tron F, Gambineri E, Bianchi L, Rodriguez-Gallego C, Zitnik SE, Vasconcelos J, Guedes M, Vitor AB, Marodi L, et al: Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells. J Exp Med. 2008, 205: 1543-1550. 10.1084/jem.20080321.PubMedCentralCrossRefPubMed de Beaucoudrey L, Puel A, Filipe-Santos O, Cobat A, Ghandil P, Chrabieh M, Feinberg J, von Bernuth H, Samarina A, Jannière L, Fieschi C, Stéphan JL, Boileau C, Lyonnet S, Jondeau G, Cormier-Daire V, Le Merrer M, Hoarau C, Lebranchu Y, Lortholary O, Chandesris MO, Tron F, Gambineri E, Bianchi L, Rodriguez-Gallego C, Zitnik SE, Vasconcelos J, Guedes M, Vitor AB, Marodi L, et al: Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells. J Exp Med. 2008, 205: 1543-1550. 10.1084/jem.20080321.PubMedCentralCrossRefPubMed
48.
go back to reference Woellner C, Gertz EM, Schäffer AA, Lagos M, Perro M, Glocker EO, Pietrogrande MC, Cossu F, Franco JL, Matamoros N, Pietrucha B, Heropolitańska-Pliszka E, Yeganeh M, Moin M, Español T, Ehl S, Gennery AR, Abinun M, Breborowicz A, Niehues T, Kilic SS, Junker A, Turvey SE, Plebani A, Sanchez B, Garty BZ, Pignata C, Cancrini C, Litzman J, Sanal O, et al: Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome. J Allergy Clin Immunol. 2010, 125: 424-432. 10.1016/j.jaci.2009.10.059.PubMedCentralCrossRefPubMed Woellner C, Gertz EM, Schäffer AA, Lagos M, Perro M, Glocker EO, Pietrogrande MC, Cossu F, Franco JL, Matamoros N, Pietrucha B, Heropolitańska-Pliszka E, Yeganeh M, Moin M, Español T, Ehl S, Gennery AR, Abinun M, Breborowicz A, Niehues T, Kilic SS, Junker A, Turvey SE, Plebani A, Sanchez B, Garty BZ, Pignata C, Cancrini C, Litzman J, Sanal O, et al: Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome. J Allergy Clin Immunol. 2010, 125: 424-432. 10.1016/j.jaci.2009.10.059.PubMedCentralCrossRefPubMed
49.
go back to reference Heimall J, Davis J, Shaw PA, Hsu AP, Gu W, Welch P, Holland SM, Freeman AF: Paucity of genotype-phenotype correlations in STAT3 mutation positive Hyper IgE Syndrome (HIES). Clin Immunol. 2011, 139: 75-84. 10.1016/j.clim.2011.01.001.PubMedCentralCrossRefPubMed Heimall J, Davis J, Shaw PA, Hsu AP, Gu W, Welch P, Holland SM, Freeman AF: Paucity of genotype-phenotype correlations in STAT3 mutation positive Hyper IgE Syndrome (HIES). Clin Immunol. 2011, 139: 75-84. 10.1016/j.clim.2011.01.001.PubMedCentralCrossRefPubMed
50.
go back to reference Takeda K, Noguchi K, Shi W, Tanaka T, Matsumoto M, Yoshida N, Kishimoto T, Akira S: Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc Natl Acad Sci USA. 1997, 94: 3801-3804. 10.1073/pnas.94.8.3801.PubMedCentralCrossRefPubMed Takeda K, Noguchi K, Shi W, Tanaka T, Matsumoto M, Yoshida N, Kishimoto T, Akira S: Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc Natl Acad Sci USA. 1997, 94: 3801-3804. 10.1073/pnas.94.8.3801.PubMedCentralCrossRefPubMed
51.
go back to reference Milner JD, Brenchley JM, Laurence A, Freeman AF, Hill BJ, Elias KM, Kanno Y, Spalding C, Elloumi HZ, Paulson ML, Davis J, Hsu A, Asher AI, O'Shea J, Holland SM, Paul WE, Douek DC: Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature. 2008, 452: 773-776. 10.1038/nature06764.PubMedCentralCrossRefPubMed Milner JD, Brenchley JM, Laurence A, Freeman AF, Hill BJ, Elias KM, Kanno Y, Spalding C, Elloumi HZ, Paulson ML, Davis J, Hsu A, Asher AI, O'Shea J, Holland SM, Paul WE, Douek DC: Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature. 2008, 452: 773-776. 10.1038/nature06764.PubMedCentralCrossRefPubMed
52.
go back to reference Puel A, Döffinger R, Natividad A, Chrabieh M, Barcenas-Morales G, Picard C, Cobat A, Ouachée-Chardin M, Toulon A, Bustamante J, Al-Muhsen S, Al-Owain M, Arkwright PD, Costigan C, McConnell V, Cant AJ, Abinun M, Polak M, Bougnéres PF, Kumararatne D, Marodi L, Nahum A, Roifman C, Blanche S, Fischer A, Bodemer C, Abel L, Lilic D, Casanova JL: Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I. J Exp Med. 2010, 207: 291-297. 10.1084/jem.20091983.PubMedCentralCrossRefPubMed Puel A, Döffinger R, Natividad A, Chrabieh M, Barcenas-Morales G, Picard C, Cobat A, Ouachée-Chardin M, Toulon A, Bustamante J, Al-Muhsen S, Al-Owain M, Arkwright PD, Costigan C, McConnell V, Cant AJ, Abinun M, Polak M, Bougnéres PF, Kumararatne D, Marodi L, Nahum A, Roifman C, Blanche S, Fischer A, Bodemer C, Abel L, Lilic D, Casanova JL: Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I. J Exp Med. 2010, 207: 291-297. 10.1084/jem.20091983.PubMedCentralCrossRefPubMed
53.
go back to reference Browne SK, Holland SM: Anti-cytokine autoantibodies explain some chronic mucocutaneous candidiasis. Immunol Cell Biol. 2010, 88: 614-615. 10.1038/icb.2010.72.PubMedCentralCrossRefPubMed Browne SK, Holland SM: Anti-cytokine autoantibodies explain some chronic mucocutaneous candidiasis. Immunol Cell Biol. 2010, 88: 614-615. 10.1038/icb.2010.72.PubMedCentralCrossRefPubMed
54.
go back to reference Kisand K, Bøe Wolff AS, Podkrajsek KT, Tserel L, Link M, Kisand KV, Ersvaer E, Perheentupa J, Erichsen MM, Bratanic N, Meloni A, Cetani F, Perniola R, Ergun- Longmire B, Maclaren N, Krohn KJ, Pura M, Schalke B, Ströbel P, Leite MI, Battelino T, Husebye ES, Peterson P, Willcox N, Meager A: Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines. J Exp Med. 2010, 207: 299-308. 10.1084/jem.20091669.PubMedCentralCrossRefPubMed Kisand K, Bøe Wolff AS, Podkrajsek KT, Tserel L, Link M, Kisand KV, Ersvaer E, Perheentupa J, Erichsen MM, Bratanic N, Meloni A, Cetani F, Perniola R, Ergun- Longmire B, Maclaren N, Krohn KJ, Pura M, Schalke B, Ströbel P, Leite MI, Battelino T, Husebye ES, Peterson P, Willcox N, Meager A: Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines. J Exp Med. 2010, 207: 299-308. 10.1084/jem.20091669.PubMedCentralCrossRefPubMed
55.
go back to reference Huang W, Na L, Fidel PL, Schwarzenberger P: Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J Infect Dis. 2004, 190: 624-631. 10.1086/422329.CrossRefPubMed Huang W, Na L, Fidel PL, Schwarzenberger P: Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J Infect Dis. 2004, 190: 624-631. 10.1086/422329.CrossRefPubMed
56.
go back to reference Aujla SJ, Chan YR, Zheng M, Fei M, Askew DJ, Pociask DA, Reinhart TA, McAllister F, Edeal J, Gaus K, Husain S, Kreindler JL, Dubin PJ, Pilewski JM, Myerburg MM, Mason CA, Iwakura Y, Kolls JK: IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat Med. 2008, 14: 275-281. 10.1038/nm1710.PubMedCentralCrossRefPubMed Aujla SJ, Chan YR, Zheng M, Fei M, Askew DJ, Pociask DA, Reinhart TA, McAllister F, Edeal J, Gaus K, Husain S, Kreindler JL, Dubin PJ, Pilewski JM, Myerburg MM, Mason CA, Iwakura Y, Kolls JK: IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat Med. 2008, 14: 275-281. 10.1038/nm1710.PubMedCentralCrossRefPubMed
58.
go back to reference Minegishi Y, Saito M, Nagasawa M, Takada H, Hara T, Tsuchiya S, Agematsu K, Yamada M, Kawamura N, Ariga T, Tsuge I, Karasuyama H: Molecular explanation for the contradiction between systemic Th17 defect and localized bacterial infection in hyper-IgE syndrome. J Exp Med. 2009, 206: 1291-1301. 10.1084/jem.20082767.PubMedCentralCrossRefPubMed Minegishi Y, Saito M, Nagasawa M, Takada H, Hara T, Tsuchiya S, Agematsu K, Yamada M, Kawamura N, Ariga T, Tsuge I, Karasuyama H: Molecular explanation for the contradiction between systemic Th17 defect and localized bacterial infection in hyper-IgE syndrome. J Exp Med. 2009, 206: 1291-1301. 10.1084/jem.20082767.PubMedCentralCrossRefPubMed
59.
go back to reference Nieminen P, Morgan NV, Fenwick AL, Parmanen S, Veistinen L, Mikkola ML, van der Spek PJ, Giraud A, Judd L, Arte S, Brueton LA, Wall SA, Mathijssen IM, Maher ER, Wilkie AO, Kreiborg S, Thesleff I: Inactivation of IL11 signaling causes craniosynostosis, delayed tooth eruption, and supernumerary teeth. Am J Hum Genet. 2011, 89: 67-81. 10.1016/j.ajhg.2011.05.024.PubMedCentralCrossRefPubMed Nieminen P, Morgan NV, Fenwick AL, Parmanen S, Veistinen L, Mikkola ML, van der Spek PJ, Giraud A, Judd L, Arte S, Brueton LA, Wall SA, Mathijssen IM, Maher ER, Wilkie AO, Kreiborg S, Thesleff I: Inactivation of IL11 signaling causes craniosynostosis, delayed tooth eruption, and supernumerary teeth. Am J Hum Genet. 2011, 89: 67-81. 10.1016/j.ajhg.2011.05.024.PubMedCentralCrossRefPubMed
60.
go back to reference Schroer N, Pahne J, Walch B, Wickenhauser C, Smola S: Molecular pathobiology of human cervical high-grade lesions: paracrine STAT3 activation in tumor-instructed myeloid cells drives local MMP-9 expression. Cancer Res. 2011, 71: 87-97. 10.1158/0008-5472.CAN-10-2193.CrossRefPubMed Schroer N, Pahne J, Walch B, Wickenhauser C, Smola S: Molecular pathobiology of human cervical high-grade lesions: paracrine STAT3 activation in tumor-instructed myeloid cells drives local MMP-9 expression. Cancer Res. 2011, 71: 87-97. 10.1158/0008-5472.CAN-10-2193.CrossRefPubMed
61.
go back to reference Song Y, Qian L, Song S, Chen L, Zhang Y, Yuan G, Zhang H, Xia Q, Hu M, Yu M, Shi M, Jiang Z, Guo N: Fra-1 and Stat3 synergistically regulate activation of human MMP-9 gene. Mol Immunol. 2008, 45: 137-143. 10.1016/j.molimm.2007.04.031.CrossRefPubMed Song Y, Qian L, Song S, Chen L, Zhang Y, Yuan G, Zhang H, Xia Q, Hu M, Yu M, Shi M, Jiang Z, Guo N: Fra-1 and Stat3 synergistically regulate activation of human MMP-9 gene. Mol Immunol. 2008, 45: 137-143. 10.1016/j.molimm.2007.04.031.CrossRefPubMed
62.
go back to reference Tsareva SA, Moriggl R, Corvinus FM, Wiederanders B, Schütz A, Kovacic B, Friedrich K: Signal transducer and activator of transcription 3 activation promotes invasive growth of colon carcinomas through matrix metalloproteinase induction. Neoplasia. 2007, 9: 279-291. 10.1593/neo.06820.PubMedCentralCrossRefPubMed Tsareva SA, Moriggl R, Corvinus FM, Wiederanders B, Schütz A, Kovacic B, Friedrich K: Signal transducer and activator of transcription 3 activation promotes invasive growth of colon carcinomas through matrix metalloproteinase induction. Neoplasia. 2007, 9: 279-291. 10.1593/neo.06820.PubMedCentralCrossRefPubMed
63.
go back to reference Sekhsaria V, Dodd LE, Hsu AP, Heimall JR, Freeman AF, Ding L, Holland SM, Uzel G: Plasma metalloproteinase levels are dysregulated in signal transducer and activator of transcription 3 mutated hyper-IgE syndrome. J Allergy Clin Immunol. 2011, 128: 1124-1127. 10.1016/j.jaci.2011.07.046.PubMedCentralCrossRefPubMed Sekhsaria V, Dodd LE, Hsu AP, Heimall JR, Freeman AF, Ding L, Holland SM, Uzel G: Plasma metalloproteinase levels are dysregulated in signal transducer and activator of transcription 3 mutated hyper-IgE syndrome. J Allergy Clin Immunol. 2011, 128: 1124-1127. 10.1016/j.jaci.2011.07.046.PubMedCentralCrossRefPubMed
64.
go back to reference Quintero PA, Knolle MD, Cala LF, Zhuang Y, Owen CA: Matrix metalloproteinase-8 inactivates macrophage inflammatory protein-1 alpha to reduce acute lung inflammation and injury in mice. J Immunol. 2010, 184: 1575-1588. 10.4049/jimmunol.0900290.PubMedCentralCrossRefPubMed Quintero PA, Knolle MD, Cala LF, Zhuang Y, Owen CA: Matrix metalloproteinase-8 inactivates macrophage inflammatory protein-1 alpha to reduce acute lung inflammation and injury in mice. J Immunol. 2010, 184: 1575-1588. 10.4049/jimmunol.0900290.PubMedCentralCrossRefPubMed
65.
go back to reference Pyo R, Lee JK, Shipley JM, Curci JA, Mao D, Ziporin SJ, Ennis TL, Shapiro SD, Senior RM, Thompson RW: Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. J Clin Invest. 2000, 105: 1641-1649. 10.1172/JCI8931.PubMedCentralCrossRefPubMed Pyo R, Lee JK, Shipley JM, Curci JA, Mao D, Ziporin SJ, Ennis TL, Shapiro SD, Senior RM, Thompson RW: Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. J Clin Invest. 2000, 105: 1641-1649. 10.1172/JCI8931.PubMedCentralCrossRefPubMed
66.
go back to reference Pradhan-Palikhe P, Vikatmaa P, Lajunen T, Palikhe A, Lepäntalo M, Tervahartiala T, Salo T, Saikku P, Leinonen M, Pussinen PJ, Sorsa : Elevated MMP-8 and decreased myeloperoxidase concentrations associate significantly with the risk for peripheral atherosclerosis disease and abdominal aortic aneurysm. Scand J Immunol. 2010, 72: 150-157. 10.1111/j.1365-3083.2010.02418.x.CrossRefPubMed Pradhan-Palikhe P, Vikatmaa P, Lajunen T, Palikhe A, Lepäntalo M, Tervahartiala T, Salo T, Saikku P, Leinonen M, Pussinen PJ, Sorsa : Elevated MMP-8 and decreased myeloperoxidase concentrations associate significantly with the risk for peripheral atherosclerosis disease and abdominal aortic aneurysm. Scand J Immunol. 2010, 72: 150-157. 10.1111/j.1365-3083.2010.02418.x.CrossRefPubMed
67.
go back to reference Grimbacher B, Schäffer AA, Holland SM, Davis J, Gallin JI, Malech HL, Atkinson TP, Belohradsky BH, Buckley RH, Cossu F, Español T, Garty BZ, Matamoros N, Myers LA, Nelson RP, Ochs HD, Renner ED, Wellinghausen N, Puck JM: Genetic linkage of hyper-IgE syndrome to chromosome 4. Am J Hum Genet. 1999, 65: 735-744. 10.1086/302547.PubMedCentralCrossRefPubMed Grimbacher B, Schäffer AA, Holland SM, Davis J, Gallin JI, Malech HL, Atkinson TP, Belohradsky BH, Buckley RH, Cossu F, Español T, Garty BZ, Matamoros N, Myers LA, Nelson RP, Ochs HD, Renner ED, Wellinghausen N, Puck JM: Genetic linkage of hyper-IgE syndrome to chromosome 4. Am J Hum Genet. 1999, 65: 735-744. 10.1086/302547.PubMedCentralCrossRefPubMed
68.
go back to reference Schimke LF, Sawalle-Belohradsky J, Roesler J, Wollenberg A, Rack A, Borte M, Rieber N, Cremer R, Maass E, Dopfer R, Reichenbach J, Wahn V, Hoenig M, Jansson AF, Roesen-Wolff A, Schaub B, Seger R, Hill HR, Ochs HD, Torgerson TR, Belohradsky BH, Renner ED: Diagnostic approach to the hyper-IgE syndromes: immunologic and clinical key findings to differentiate hyper-IgE syndromes from atopic dermatitis. J Allergy Clin Immunol. 2010, 126: 611-617. 10.1016/j.jaci.2010.06.029.CrossRefPubMed Schimke LF, Sawalle-Belohradsky J, Roesler J, Wollenberg A, Rack A, Borte M, Rieber N, Cremer R, Maass E, Dopfer R, Reichenbach J, Wahn V, Hoenig M, Jansson AF, Roesen-Wolff A, Schaub B, Seger R, Hill HR, Ochs HD, Torgerson TR, Belohradsky BH, Renner ED: Diagnostic approach to the hyper-IgE syndromes: immunologic and clinical key findings to differentiate hyper-IgE syndromes from atopic dermatitis. J Allergy Clin Immunol. 2010, 126: 611-617. 10.1016/j.jaci.2010.06.029.CrossRefPubMed
69.
go back to reference Sheerin KA, Buckley RH: Antibody responses to protein, polysaccharide, and phi X174 antigens in the hyperimmunoglobulinemia E (hyper-IgE) syndrome. J Allergy Clin Immunol. 1991, 87: 803-811. 10.1016/0091-6749(91)90126-9.CrossRefPubMed Sheerin KA, Buckley RH: Antibody responses to protein, polysaccharide, and phi X174 antigens in the hyperimmunoglobulinemia E (hyper-IgE) syndrome. J Allergy Clin Immunol. 1991, 87: 803-811. 10.1016/0091-6749(91)90126-9.CrossRefPubMed
70.
go back to reference Wakim M, Alazard M, Yajima A, Speights D, Saxon A, Stiehm ER: High dose intravenous immunoglobulin in atopic dermatitis and hyper-IgE syndrome. Ann Allergy Asthma Immunol. 1998, 81: 153-158. 10.1016/S1081-1206(10)62802-5.CrossRefPubMed Wakim M, Alazard M, Yajima A, Speights D, Saxon A, Stiehm ER: High dose intravenous immunoglobulin in atopic dermatitis and hyper-IgE syndrome. Ann Allergy Asthma Immunol. 1998, 81: 153-158. 10.1016/S1081-1206(10)62802-5.CrossRefPubMed
71.
go back to reference Nester TA, Wagnon AH, Reilly WF, Spitzer G, Kjeldsberg CR, Hill HR: Effects of allogeneic peripheral stem cell transplantation in a patient with job syndrome of hyperimmunoglobulinemia E and recurrent infections. Am J Med. 1998, 105: 162-164. 10.1016/S0002-9343(98)00200-9.CrossRefPubMed Nester TA, Wagnon AH, Reilly WF, Spitzer G, Kjeldsberg CR, Hill HR: Effects of allogeneic peripheral stem cell transplantation in a patient with job syndrome of hyperimmunoglobulinemia E and recurrent infections. Am J Med. 1998, 105: 162-164. 10.1016/S0002-9343(98)00200-9.CrossRefPubMed
72.
go back to reference Gennery AR, Flood TJ, Abinun M, Cant AJ: Bone marrow transplantation does not correct the hyper IgE syndrome. Bone Marrow Transplant. 2000, 25: 1303-1305. 10.1038/sj.bmt.1702446.CrossRefPubMed Gennery AR, Flood TJ, Abinun M, Cant AJ: Bone marrow transplantation does not correct the hyper IgE syndrome. Bone Marrow Transplant. 2000, 25: 1303-1305. 10.1038/sj.bmt.1702446.CrossRefPubMed
73.
go back to reference Goussetis E, Peristeri I, Kitra V, Traeger-Synodinos J, Theodosaki M, Psarra K, Kanariou M, Tzortzatou-Stathopoulou F, Petrakou E, Fylaktou I, Kanavakis E, Graphakos S: Successful long-term immunologic reconstitution by allogeneic hematopoietic stem cell transplantation cures patients with autosomal dominant hyper-IgE syndrome. J Allergy Clin Immunol. 2010, 126: 392-394. 10.1016/j.jaci.2010.05.005.CrossRefPubMed Goussetis E, Peristeri I, Kitra V, Traeger-Synodinos J, Theodosaki M, Psarra K, Kanariou M, Tzortzatou-Stathopoulou F, Petrakou E, Fylaktou I, Kanavakis E, Graphakos S: Successful long-term immunologic reconstitution by allogeneic hematopoietic stem cell transplantation cures patients with autosomal dominant hyper-IgE syndrome. J Allergy Clin Immunol. 2010, 126: 392-394. 10.1016/j.jaci.2010.05.005.CrossRefPubMed
74.
go back to reference Renner ED, Puck JM, Holland SM, Schmitt M, Weiss M, Frosch M, Bergmann M, Davis J, Belohradsky BH, Grimbacher B: Autosomal recessive hyperimmunoglobulin E syndrome: a distinct disease entity. J Pediatr. 2004, 144: 93-99. 10.1016/S0022-3476(03)00449-9.CrossRefPubMed Renner ED, Puck JM, Holland SM, Schmitt M, Weiss M, Frosch M, Bergmann M, Davis J, Belohradsky BH, Grimbacher B: Autosomal recessive hyperimmunoglobulin E syndrome: a distinct disease entity. J Pediatr. 2004, 144: 93-99. 10.1016/S0022-3476(03)00449-9.CrossRefPubMed
75.
go back to reference Zhang Q, Davis JC, Dove CG, Su HC: Genetic, clinical, and laboratory markers for DOCK8 immunodeficiency syndrome. Dis Markers. 2010, 29: 131-139.CrossRefPubMed Zhang Q, Davis JC, Dove CG, Su HC: Genetic, clinical, and laboratory markers for DOCK8 immunodeficiency syndrome. Dis Markers. 2010, 29: 131-139.CrossRefPubMed
76.
go back to reference Engelhardt KR, McGhee S, Winkler S, Sassi A, Woellner C, Lopez-Herrera G, Chen A, Kim HS, Lloret MG, Schulze I, Ehl S, Thiel J, Pfeifer D, Veelken H, Niehues T, Siepermann K, Weinspach S, Reisli I, Keles S, Genel F, Kutukculer N, Camcioğlu Y, Somer A, Karakoc-Aydiner E, Barlan I, Gennery A, Metin A, Degerliyurt A, Pietrogrande MC, Yeganeh M, et al: Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome. J Allergy Clin Immunol. 2009, 124: 1289-1302. 10.1016/j.jaci.2009.10.038.PubMedCentralCrossRefPubMed Engelhardt KR, McGhee S, Winkler S, Sassi A, Woellner C, Lopez-Herrera G, Chen A, Kim HS, Lloret MG, Schulze I, Ehl S, Thiel J, Pfeifer D, Veelken H, Niehues T, Siepermann K, Weinspach S, Reisli I, Keles S, Genel F, Kutukculer N, Camcioğlu Y, Somer A, Karakoc-Aydiner E, Barlan I, Gennery A, Metin A, Degerliyurt A, Pietrogrande MC, Yeganeh M, et al: Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome. J Allergy Clin Immunol. 2009, 124: 1289-1302. 10.1016/j.jaci.2009.10.038.PubMedCentralCrossRefPubMed
77.
go back to reference Harada Y, Tanaka Y, Terasawa M, Pieczyk M, Habiro K, Katakai T, Hanawa- Suetsugu K, Kukimoto-Niino M, Nishizaki T, Shirouzu M, Duan X, Uruno T, Nishikimi A, Sanematsu F, Yokoyama S, Stein JV, Kinashi T, Fukui Y: DOCK8 is a Cdc42 activator critical for interstitial dendritic cell migration during immune responses. Blood. 2012, 119: 4451-4461. 10.1182/blood-2012-01-407098.PubMedCentralCrossRefPubMed Harada Y, Tanaka Y, Terasawa M, Pieczyk M, Habiro K, Katakai T, Hanawa- Suetsugu K, Kukimoto-Niino M, Nishizaki T, Shirouzu M, Duan X, Uruno T, Nishikimi A, Sanematsu F, Yokoyama S, Stein JV, Kinashi T, Fukui Y: DOCK8 is a Cdc42 activator critical for interstitial dendritic cell migration during immune responses. Blood. 2012, 119: 4451-4461. 10.1182/blood-2012-01-407098.PubMedCentralCrossRefPubMed
78.
go back to reference Jabara HH, McDonald DR, Janssen E, Massaad MJ, Ramesh N, Borzutzky A, Rauter I, Benson H, Schneider L, Baxi S, Recher M, Notarangelo LD, Wakim R, Dbaibo G, Dasouki M, Al-Herz W, Barlan I, Baris S, Kutukculer N, Ochs HD, Plebani A, Kanariou M, Lefranc G, Reisli I, Fitzgerald KA, Golenbock D, Manis J, Keles S, Ceja R, Chatila TA, Geha RS: DOCK8 functions as an adaptor that links TLR-MyD88 signaling to B cell activation. Nat Immunol. 2012, 13: 612-620. 10.1038/ni.2305.PubMedCentralCrossRefPubMed Jabara HH, McDonald DR, Janssen E, Massaad MJ, Ramesh N, Borzutzky A, Rauter I, Benson H, Schneider L, Baxi S, Recher M, Notarangelo LD, Wakim R, Dbaibo G, Dasouki M, Al-Herz W, Barlan I, Baris S, Kutukculer N, Ochs HD, Plebani A, Kanariou M, Lefranc G, Reisli I, Fitzgerald KA, Golenbock D, Manis J, Keles S, Ceja R, Chatila TA, Geha RS: DOCK8 functions as an adaptor that links TLR-MyD88 signaling to B cell activation. Nat Immunol. 2012, 13: 612-620. 10.1038/ni.2305.PubMedCentralCrossRefPubMed
79.
go back to reference Randall KL, Chan SS, Ma CS, Fung I, Mei Y, Yabas M, Tan A, Arkwright PD, Al Suwairi W, Lugo Reyes SO, Yamazaki-Nakashimada MA, Garcia-Cruz Mde L, Smart JM, Picard C, Okada S, Jouanguy E, Casanova JL, Lambe T, Cornall RJ, Russell S, Oliaro J, Tangye SG, Bertram EM, Goodnow CC: DOCK8 deficiency impairs CD8 T cell survival and function in humans and mice. J Exp Med. 2011, 208: 2305-2320. 10.1084/jem.20110345.PubMedCentralCrossRefPubMed Randall KL, Chan SS, Ma CS, Fung I, Mei Y, Yabas M, Tan A, Arkwright PD, Al Suwairi W, Lugo Reyes SO, Yamazaki-Nakashimada MA, Garcia-Cruz Mde L, Smart JM, Picard C, Okada S, Jouanguy E, Casanova JL, Lambe T, Cornall RJ, Russell S, Oliaro J, Tangye SG, Bertram EM, Goodnow CC: DOCK8 deficiency impairs CD8 T cell survival and function in humans and mice. J Exp Med. 2011, 208: 2305-2320. 10.1084/jem.20110345.PubMedCentralCrossRefPubMed
81.
go back to reference Lambe T, Crawford G, Johnson AL, Crockford TL, Bouriez-Jones T, Smyth AM, Pham TH, Zhang Q, Freeman AF, Cyster JG, Su HC, Cornall RJ: DOCK8 is essential for T-cell survival and the maintenance of CD8+ T-cell memory. Eur J Immunol. 2011, 41: 3423-3435. 10.1002/eji.201141759.PubMedCentralCrossRefPubMed Lambe T, Crawford G, Johnson AL, Crockford TL, Bouriez-Jones T, Smyth AM, Pham TH, Zhang Q, Freeman AF, Cyster JG, Su HC, Cornall RJ: DOCK8 is essential for T-cell survival and the maintenance of CD8+ T-cell memory. Eur J Immunol. 2011, 41: 3423-3435. 10.1002/eji.201141759.PubMedCentralCrossRefPubMed
82.
go back to reference Sanal O, Jing H, Ozgur T, Ayvaz D, Strauss-Albee DM, Ersoy-Evans S, Tezcan I, Turkkani G, Matthews HF, Haliloglu G, Yuce A, Yalcin B, Gokoz O, Oguz KK, Su HC: Additional diverse findings expand the clinical presentation of DOCK8 deficiency. J Clin Immunol. 2012, 32: 698-708. 10.1007/s10875-012-9664-5.PubMedCentralCrossRefPubMed Sanal O, Jing H, Ozgur T, Ayvaz D, Strauss-Albee DM, Ersoy-Evans S, Tezcan I, Turkkani G, Matthews HF, Haliloglu G, Yuce A, Yalcin B, Gokoz O, Oguz KK, Su HC: Additional diverse findings expand the clinical presentation of DOCK8 deficiency. J Clin Immunol. 2012, 32: 698-708. 10.1007/s10875-012-9664-5.PubMedCentralCrossRefPubMed
83.
go back to reference Gatz SA, Benninghoff U, Schütz C, Schulz A, Hönig M, Pannicke U, Holzmann KH, Schwarz K, Friedrich W: Curative treatment of autosomal-recessive hyper-IgE syndrome by hematopoietic cell transplantation. Bone Marrow Transplant. 2011, 46: 552-556. 10.1038/bmt.2010.169.CrossRefPubMed Gatz SA, Benninghoff U, Schütz C, Schulz A, Hönig M, Pannicke U, Holzmann KH, Schwarz K, Friedrich W: Curative treatment of autosomal-recessive hyper-IgE syndrome by hematopoietic cell transplantation. Bone Marrow Transplant. 2011, 46: 552-556. 10.1038/bmt.2010.169.CrossRefPubMed
84.
go back to reference Bittner TC, Pannicke U, Renner ED, Notheis G, Hoffmann F, Belohradsky BH, Wintergerst U, Hauser M, Klein B, Schwarz K, Schmid I, Albert MH: Successful long-term correction of autosomal recessive hyper-IgE syndrome due to DOCK8 deficiency by hematopoietic stem cell transplantation. Klin Padiatr. 2010, 222: 351-355. 10.1055/s-0030-1265135.CrossRefPubMed Bittner TC, Pannicke U, Renner ED, Notheis G, Hoffmann F, Belohradsky BH, Wintergerst U, Hauser M, Klein B, Schwarz K, Schmid I, Albert MH: Successful long-term correction of autosomal recessive hyper-IgE syndrome due to DOCK8 deficiency by hematopoietic stem cell transplantation. Klin Padiatr. 2010, 222: 351-355. 10.1055/s-0030-1265135.CrossRefPubMed
85.
go back to reference Barlogis V, Galambrun C, Chambost H, Lamoureux-Toth S, Petit P, Stephan JL, Michel G, Fischer A, Picard C: Successful allogeneic hematopoietic stem cell transplantation for DOCK8 deficiency. J Allergy Clin Immunol. 2011, 128: 420-422. 10.1016/j.jaci.2011.03.025.CrossRefPubMed Barlogis V, Galambrun C, Chambost H, Lamoureux-Toth S, Petit P, Stephan JL, Michel G, Fischer A, Picard C: Successful allogeneic hematopoietic stem cell transplantation for DOCK8 deficiency. J Allergy Clin Immunol. 2011, 128: 420-422. 10.1016/j.jaci.2011.03.025.CrossRefPubMed
86.
go back to reference Metin A, Tavil B, Azık F, Azkur D, Ok-Bozkaya I, Kocabas C, Tunc B, Uckan D: Successful bone marrow transplantation for DOCK8 deficient hyper IgE syndrome. Pediatr Transplant. 2012, 16: 398-399. 10.1111/j.1399-3046.2011.01641.x.CrossRefPubMed Metin A, Tavil B, Azık F, Azkur D, Ok-Bozkaya I, Kocabas C, Tunc B, Uckan D: Successful bone marrow transplantation for DOCK8 deficient hyper IgE syndrome. Pediatr Transplant. 2012, 16: 398-399. 10.1111/j.1399-3046.2011.01641.x.CrossRefPubMed
87.
go back to reference Minegishi Y, Saito M, Morio T, Watanabe K, Agematsu K, Tsuchiya S, Takada H, Hara T, Kawamura N, Ariga T, Kaneko H, Kondo N, Tsuge I, Yachie A, Sakiyama Y, Iwata T, Bessho F, Ohishi T, Joh K, Imai K, Kogawa K, Shinohara M, Fujieda M, Wakiguchi H, Pasic S, Abinun M, Ochs HD, Renner ED, Jansson A, Belohradsky BH, et al: Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity. Immunity. 2006, 25: 745-755. 10.1016/j.immuni.2006.09.009.CrossRefPubMed Minegishi Y, Saito M, Morio T, Watanabe K, Agematsu K, Tsuchiya S, Takada H, Hara T, Kawamura N, Ariga T, Kaneko H, Kondo N, Tsuge I, Yachie A, Sakiyama Y, Iwata T, Bessho F, Ohishi T, Joh K, Imai K, Kogawa K, Shinohara M, Fujieda M, Wakiguchi H, Pasic S, Abinun M, Ochs HD, Renner ED, Jansson A, Belohradsky BH, et al: Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity. Immunity. 2006, 25: 745-755. 10.1016/j.immuni.2006.09.009.CrossRefPubMed
88.
go back to reference Kilic SS, Hacimustafaoglu M, Boisson-Dupuis S, Kreins AY, Grant AV, Abel L, Casanova JL: A patient with tyrosine kinase 2 deficiency without hyper-IgE syndrome. J Pediatr. 2012, 160: 1055-1057. 10.1016/j.jpeds.2012.01.056.PubMedCentralCrossRefPubMed Kilic SS, Hacimustafaoglu M, Boisson-Dupuis S, Kreins AY, Grant AV, Abel L, Casanova JL: A patient with tyrosine kinase 2 deficiency without hyper-IgE syndrome. J Pediatr. 2012, 160: 1055-1057. 10.1016/j.jpeds.2012.01.056.PubMedCentralCrossRefPubMed
89.
go back to reference Antoniades K, Hatzistilianou M, Pitsavas G, Agouridaki C, Athanassiadou F: Co-existence of Dubowitz and hyper-IgE syndromes: a case report. Eur J Pediatr. 1996, 155: 390-392. 10.1007/BF01955268.CrossRefPubMed Antoniades K, Hatzistilianou M, Pitsavas G, Agouridaki C, Athanassiadou F: Co-existence of Dubowitz and hyper-IgE syndromes: a case report. Eur J Pediatr. 1996, 155: 390-392. 10.1007/BF01955268.CrossRefPubMed
90.
go back to reference Boeck A, Gfatter R, Braun F, Fritz B: Pentasomy × and hyper IgE syndrome: co-existence of two distinct genetic disorders. Eur J Pediatr. 1999, 158: 723-726. 10.1007/s004310051187.CrossRefPubMed Boeck A, Gfatter R, Braun F, Fritz B: Pentasomy × and hyper IgE syndrome: co-existence of two distinct genetic disorders. Eur J Pediatr. 1999, 158: 723-726. 10.1007/s004310051187.CrossRefPubMed
91.
go back to reference Boeck A, Kosan C, Ciznar P, Kunz J: Saethre-Chotzen syndrome and hyper IgE syndrome in a patient with a novel 11 bp deletion of the TWIST gene. Am J Med Genet. 2001, 104: 53-56. 10.1002/ajmg.10007.CrossRefPubMed Boeck A, Kosan C, Ciznar P, Kunz J: Saethre-Chotzen syndrome and hyper IgE syndrome in a patient with a novel 11 bp deletion of the TWIST gene. Am J Med Genet. 2001, 104: 53-56. 10.1002/ajmg.10007.CrossRefPubMed
Metadata
Title
An update on the hyper-IgE syndromes
Authors
Patrick FK Yong
Alexandra F Freeman
Karin R Engelhardt
Steven Holland
Jennifer M Puck
Bodo Grimbacher
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 6/2012
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar4069

Other articles of this Issue 6/2012

Arthritis Research & Therapy 6/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine